Form 4: Sotera Health Director Ann R. Klee Reports Acquisition of Restricted Stock Units

Director Ann R. Klee reports the acquisition of 20,089 Restricted Stock Units (RSUs) in Sotera Health Co.

Summary

• On May 24, 2024, Ann R. Klee, a director of Sotera Health Co., acquired 20,089 Restricted Stock Units (RSUs).
• These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock, subject to vesting conditions.
• The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent upon continued service as a non-employee director.
• Following this transaction, Klee beneficially owns a total of 106,824 shares, including the newly acquired RSUs and existing shares of Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of RSUs by a director is generally seen as a positive sign, indicating confidence in the company's future. The vesting conditions further align the director's interests with those of the shareholders.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders.
• The vesting conditions tied to continued service encourage long-term commitment from the director.

Future Outlook

The RSUs will vest based on continued service as a non-employee director, aligning the director's interests with the company's long-term performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Granting RSUs to directors is a common practice among publicly traded companies to incentivize and align their interests with shareholders.
• Vesting schedules tied to continued service are also standard, ensuring directors remain committed to the company's success.
• The Sotera Health Company 2020 Omnibus Incentive Plan is similar to incentive plans offered by comparable companies such as Steris and Baxter International.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign, aligning director interests with company performance.
• The director is incentivized to contribute to the company's success to ensure vesting of the RSUs.

Key Dates